Medical Devices
Home » Venous Thromboembolism (VTE) Treatment Market

Global Venous Thromboembolism (VTE) Treatment Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast 2016 – 2030

Price: $4999

Published: | Report ID: 11666 | Category: Medical Devices

Key Highlights of the Report

How are the major segments performing in the Venous Thromboembolism (VTE) Treatment market?

  • The catheter-directed thrombolysis (CDT) devices product segment holds the largest global market share in 2022 and is estimated to increase fastest in the projected period. Catheter-directed thrombolysis devices are a popular addition to percutaneous mechanical thrombectomy devices, which use X-ray imaging to guide a medical device or drug to the location of blood clots to dissolve them. As a result, increasing patient preference for minimally invasive treatments for treating pulmonary embolism is fueling demand for such venous thromboembolism management devices, driving the segment growth.
  • In 2022, the deep vein thrombosis type segment was anticipated to hold a prominent global venous thromboembolism (VTE) treatment market share. The rising risk of blood clots, which cause deep venous thrombosis, due to rising cancer, pregnancy, and cardiovascular disease cases, particularly in developing economies such as India, China, Germany, Australia, and others, is driving demand for deep venous thrombosis segment.
  • The hospital end-users category was the largest in 2022 and is expected to increase at the highest rate during the upcoming years. Hospitals are the primary healthcare settings where patients receive diagnosis, treatment, and care for VTE. Hospitals globally are equipped with highly advanced medical technologies and infrastructure, allowing for accurate diagnosis and effective treatment of VTE.
  • The hospital pharmacy distribution channel category accounted for the largest revenue share of this market in 2022 and is estimated to grow at the highest CAGR in the projected period. Hospital pharmacies serve as important intermediaries between manufacturers or suppliers of VTE treatment medications and healthcare providers, specifically within hospital settings. Hospital pharmacies are crucial in ensuring the availability, procurement, storage, and distribution of VTE treatment drugs within hospital premises.

What is the Market Size of Venous Thromboembolism (VTE) Treatment regarding value?

The global venous thromboembolism (VTE) treatment market is projected to grow at a substantial CAGR of 8.9% over the upcoming years. The global Venous Thromboembolism (VTE) Treatment industry was estimated to be worth USD 1.1 billion in 2022 and is expected to be USD 1.99 billion by 2030.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

CTA Design Element 3

Which region dominated the venous thromboembolism (VTE) treatment market?

In 2022, North America led the global venous thromboembolism (VTE) treatment market in terms of revenue share, owing to a high prevalence of VTE, a well-established healthcare infrastructure, advanced medical technology, and a strong focus on R&D operations. Additionally, increased awareness among healthcare professionals and patients about the importance of early treatment and detection of VTE has contributed to the market growth in this region. The presence of major market players and ongoing advancements in VTE treatment options also contribute to regional dominance in the global market.

Which are the key countries in the venous thromboembolism (VTE) treatment market?

As one of the largest healthcare markets globally, the United States plays a key role in the VTE treatment market. The country has a high prevalence of VTE cases and a well-established healthcare infrastructure, leading to a strong demand for VTE treatment options. According to the American Heart Association, around 900,000 people in the US are affected by VTE annually, which is estimated to be responsible for around 100,000 deaths annually. Besides, the United States is at the forefront of medical research and development, with numerous pharmaceutical companies and research institutions actively advancing VTE treatment. The country also has a strong regulatory framework, including the FDA, which is crucial in drug approvals and safety monitoring.

Germany is recognized for its advanced healthcare system and high-quality medical care. The country’s healthcare infrastructure, including specialized hospitals and healthcare centers, offers comprehensive VTE treatment services. Germany strongly emphasizes research and development, with significant investments in medical innovations and clinical trials related to VTE treatment. The country also has a well-established pharmaceutical industry, with companies actively developing and commercializing novel VTE treatment options. Moreover, Germany’s robust healthcare reimbursement system ensures that VTE patients can access effective treatment modalities without significant financial burdens.

How is the economy impacting global venous thromboembolism (VTE) treatment growth?

Economic downturns, such as impending recessions, can considerably impact market growth. Healthcare spending may be reduced during economic downturns, resulting in potential financial limits and restricted access to treatment alternatives. Besides, inflation can raise the cost of medical supplies and services, affecting the affordability and availability of VTE treatments. Geopolitical tensions, such as the present Russia-Ukraine conflict, further indirectly impact the global economy and, as a result, the VTE treatment industry. These tensions can disrupt commerce, investment, and overall economic stability, affecting healthcare systems and slowing market growth.

What is the competitive environment of the venous thromboembolism (VTE) treatment market?

The competitive environment of the venous thromboembolism (VTE) therapy market is characterized by several established pharmaceutical businesses, medical device manufacturers, and biotechnology enterprises. These firms compete based on their product portfolio, therapeutic efficacy, safety profile, cost, and geographic reach. There is an extensive focus on R&D activities to bring new and improved treatment options for VTE, such as novel anticoagulant medicines, medical devices, and combination therapy. Moreover, the global market is influenced by regulatory constraints, patent expirations, and pricing pressures, all of which contribute to the competitive dynamics of the VTE treatment industry. For example, Pfizer Inc gained FDA approval for FRAGMIN, a dalteparin sodium to reduce the recurrence of venous thromboembolism (VTE) in pediatric patients aged one month and up, in May 2019.

Executive Summary

What are the key trends in the Venous Thromboembolism (VTE) Treatment market?

  • Growing adoption of direct oral anticoagulants (DOACs) as a preferred treatment option over traditional anticoagulants like warfarin: DOACs provide several advantages, including predictable pharmacokinetics, fewer drug-drug and drug-food interactions, and no need for frequent monitoring. They have demonstrated comparable or enhanced efficacy and safety outcomes compared to standard anticoagulants, resulting in increased use in preventing and treating VTE. The expanding quantity of clinical evidence supporting their usefulness and the convenience they provide patients is driving the transition toward DOACs. Furthermore, advances in personalized medicine and genetic testing are adding to the trend by assisting in identifying patients most likely to benefit from DOAC therapy.

What are the latest technological advancements in the venous thromboembolism (VTE) treatment market?

The most recent technological advances in treating venous thromboembolism (VTE) involve the development of new anticoagulants with improved safety and efficacy characteristics. This includes the launch of direct oral anticoagulants (DOACs), which target specific coagulation factors like factor Xa or thrombin and offer benefits over traditional anticoagulants. Furthermore, progress has been made in developing long-term anticoagulant treatments to prevent recurrent VTE, providing alternatives to traditional treatment durations. In addition, technical advances in medical technologies, such as catheter-based therapies, such as catheter-directed thrombolysis and mechanical thrombectomy procedures, are being investigated to treat VTE. These technological innovations aim to improve treatment outcomes, lower the risk of bleeding problems, and improve overall VTE patient management.

Venous Thromboembolism (VTE) Treatment Market

Which are the key investments by the venous thromboembolism (VTE) treatment market players?

The direct investments of venous thromboembolism (VTE) therapy market participants include R&D initiatives to bring novel medications and treatment choices. This includes investing in clinical trials to assess the efficacy and safety of new medications and medical technologies for VTE treatment. Market players also collaborate with academic institutions, research organizations, and other industry players to leverage their expertise and resources in advancing VTE treatment. Additionally, investments are made in marketing and promotional activities to raise awareness about VTE and its treatment options among healthcare professionals and patients. Companies also invest in expanding their manufacturing capacities and distribution networks to ensure the availability and accessibility of VTE treatment products globally.

Major venous thromboembolism (VTE) treatment market players are Pfizer Inc (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Mylan N.V. (U.S.), Aspen Holdings (U.S.), Fresenius Kabi AG (Germany), Hebei Changshan Biochemical Pharmaceutical Co. Ltd (China), Hikma Pharmaceuticals PLC (U.K.), Novartis AG (Switzerland), and Janssen Global Services LLC (U.S.).

What are the Major Driving Factors for the Venous Thromboembolism (VTE) Treatment Market?

The major driving factors for the venous thromboembolism (VTE) treatment market include the increasing prevalence of VTE disorders, rising awareness about VTE and its complications, advancements in diagnostic techniques, and the growing aging population. The development of novel treatment options and therapeutic drugs, favorable reimbursement policies, and the increasing adoption of minimally invasive procedures drive market expansion. The emerging incidence of risk factors such as obesity, sedentary lifestyles, and chronic diseases further contribute to the demand for VTE treatment. Moreover, infrastructure development, growing healthcare expenditure, and government initiatives to improve VTE diagnosis and treatment propel market growth.

What are the Major Risks for the Venous Thromboembolism (VTE) Treatment Market?

The high cost of treatment, particularly for long-term management, is a major limitation for the venous thromboembolism (VTE) treatment market, as it can limit access to care for specific patient populations. A lack of awareness and underdiagnosis complicates VTE treatment and prevention. Besides, the regulatory criteria and approval processes for new VTE therapy medications can be time-consuming and expensive, impeding the market release of innovative therapies.

Which is the key type in the venous thromboembolism (VTE) treatment market?

Deep vein thrombosis (DVT) will have a major global venous thromboembolism (VTE) therapy market revenue share in the upcoming years. DVT is the formation of blood clots within deep veins, most commonly in the legs. It is a dangerous illness requiring immediate diagnosis and treatment to avoid consequences like pulmonary embolism. The DVT-type segment of the VTE therapy market focuses on meeting the specific needs of patients with deep vein thrombosis. This category includes a variety of therapeutic methods and treatments aimed at dissolving or preventing the formation of blood clots, alleviating symptoms, and lowering the risk of recurrence. Anticoagulant medicines are essential in the treatment of DVT. These drugs, such as heparin and warfarin, aid in the prevention of new blood clot formation and prevent existing clots from growing larger.

How is the venous thromboembolism (VTE) treatment market performing in regions?

In the forecasting years, the Asia Pacific will likely witness the fastest CAGR growth in the global venous thromboembolism (VTE) treatment market. This increase can be linked to various factors, including the increasing regional prevalence of VTE, rising healthcare expenditure, improved healthcare infrastructure, and an aging population. Moreover, implementing government programs to promote awareness about VTE and its treatment and the availability of modern medical technology contribute to the rapid expansion of the Asia-Pacific VTE treatment market. Countries with substantial population bases and expanding healthcare investments, such as China and India, will likely drive significant development.

What is the regulatory landscape for the venous thromboembolism (VTE) treatment market?

The regulatory landscape for the venous thromboembolism (VTE) treatment market involves various regulatory authorities and guidelines that ensure the safety and efficacy of treatments. Regulatory bodies such as the U.S. FDA, European Medicines Agency (EMA), and other regional health authorities have specific regulations to approve and market VTE treatment drugs and devices. These regulations focus on factors like clinical trials, labeling requirements, post-market surveillance, and adverse event reporting to ensure patient safety. Compliance with these regulations is crucial for companies operating in the VTE treatment market to bring their products to market and maintain their presence in the industry.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

What are the major players planning for the future of the venous thromboembolism (VTE) treatment market?

Major competitors in the venous thromboembolism (VTE) treatment industry are continuously engaged in research and development to seek novel therapeutic alternatives. They are increasing their product ranges, cooperating with healthcare organizations, and investing in technology advancements. Their primary goal is to improve patient care, treatment outcomes and provide more efficient VTE solutions. These players are dedicated to driving developments in the sector and substantially impacting VTE management. For instance, Janssen Pharmaceuticals Inc, a Belgian pharmaceutical company, announced in June 2021 that its new medicine XARELTO (rivaroxaban), has received FDA approval for treating two indications: deep venous thrombosis and pulmonary embolism. This will help the organization increase its global market position.

REPORT ATTRIBUTE DETAILS
Venous Thromboembolism (VTE) Treatment Market by Volume Yes
Venous Thromboembolism (VTE) Treatment Market by Value Yes
Venous Thromboembolism (VTE) Treatment Market, Tornado Analysis Yes
Venous Thromboembolism (VTE) Treatment Market, STAR Analysis Yes
Venous Thromboembolism (VTE) Treatment Market, SRC Analysis Yes
Venous Thromboembolism (VTE) Treatment Market, Import-Export Data Yes (On Demand)
Venous Thromboembolism (VTE) Treatment Market Pricing Analysis Yes (On Demand)
Venous Thromboembolism (VTE) Treatment Market Segment Analysis By Product (Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Non-Segmented Pneumatic Compression Pumps, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters, Upper Pneumatic Compression Sleeves, Percutaneous Thrombectomy Devices, Retrievable Inferior Vena Cava Filters, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices)

By Type (Deep Vein Thrombosis, Pulmonary Embolism, Others)

By End-Users (Hospitals, Homecare, Speciality Centres, Others)

By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Venous Thromboembolism (VTE) Treatment Market, Regional Analysis North America (US, Canada, Mexico)

Europe (UK, France, Germany, Italy, Spain, and the Rest of Europe)

Asia Pacific (India, Japan, China, South Korea, South East Asia, and Rest of Asia Pacific)

Latin America (Argentina, Brazil, and the Rest of Latin America)

Middle East and Africa (GCC Countries, South Africa, and the Rest of Middle East and Africa)

Venous Thromboembolism (VTE) Treatment Market, Key Companies Pfizer Inc (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Mylan N.V. (U.S.), Aspen Holdings (U.S.), Fresenius Kabi AG (Germany), Hebei Changshan Biochemical Pharmaceutical Co. Ltd (China), Hikma Pharmaceuticals PLC (U.K.), Novartis AG (Switzerland), Janssen Global Services LLC (U.S.)
Venous Thromboembolism (VTE) Treatment Market Competitive Landscape Competitive Benchmarking

Market Share Analysis

Key Players Market Positioning

Major Strategies Adopted

Geographical Presence Analysis

Segmentation of Global Venous Thromboembolism (VTE) Treatment Market-

Global Venous Thromboembolism (VTE) Treatment Market – By Product

  • Non-Segmented Pneumatic Compression Pumps
  • Segmented Pneumatic Compression Pumps without Gradient
  • Segmented Pneumatic Compression Pumps with Calibrated Gradient
  • Upper Pneumatic Compression Sleeves
  • Lower Pneumatic Compression Sleeves
  • Permanent Inferior Vena Cava Filters
  • Retrievable Inferior Vena Cava Filters
  • Embolectomy Balloon Catheters
  • Percutaneous Thrombectomy Devices
  • Catheter-Directed Thrombolysis (CDT) Devices

Global Venous Thromboembolism (VTE) Treatment Market – By Type

  • Deep Vein Thrombosis
  • Pulmonary Embolism
  • Others

Global Venous Thromboembolism (VTE) Treatment Market – By End-Users

  • Hospitals
  • Homecare
  • Specialty Centres
  • Others

Global Venous Thromboembolism (VTE) Treatment Market – By Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Global Venous Thromboembolism (VTE) Treatment Market – By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue-Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Venous Thromboembolism (VTE) Treatment Market
2.2. Global Venous Thromboembolism (VTE) Treatment Market, By Type
2.3. Global Venous Thromboembolism (VTE) Treatment Market, By Product
2.4. Global Venous Thromboembolism (VTE) Treatment Market, By Distribution Channel
2.5. Global Venous Thromboembolism (VTE) Treatment Market, By End-Users
2.6. Global Venous Thromboembolism (VTE) Treatment Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Venous Thromboembolism (VTE) Treatment Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.2.4. Major Industry Challenges
3.2.4.1. Challenge 1
3.2.4.2. Challenge 2
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type
3.5.2. Product
3.5.3. Distribution Channel
3.5.4. End-Users
3.5.5. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company Market Share of Key Players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Venous Thromboembolism (VTE) Treatment Market, By Type
7.1. Global Venous Thromboembolism (VTE) Treatment Market Overview, by Type
7.1.1. Global Venous Thromboembolism (VTE) Treatment Market Revenue Share, By Type, 2022 Vs 2030 (in %)
7.2. Deep Vein Thrombosis
7.2.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)
7.3. Pulmonary Embolism
7.3.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)
7.4. Others
7.4.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)

8. Global Venous Thromboembolism (VTE) Treatment Market, By Product
8.1. Global Venous Thromboembolism (VTE) Treatment Market Overview, by Product
8.1.1. Global Venous Thromboembolism (VTE) Treatment Market, By Product, 2022 vs 2030 (in %)
8.2. Non-Segmented Pneumatic Compression Pumps
8.2.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)
8.3. Segmented Pneumatic Compression Pumps without Gradient
8.3.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)
8.4. Segmented Pneumatic Compression Pumps with Calibrated Gradient
8.4.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)
8.5. Upper Pneumatic Compression Sleeves
8.5.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)
8.6. Lower Pneumatic Compression Sleeves
8.6.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)
8.7. Permanent Inferior Vena Cava Filters
8.7.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)
8.8. Retrievable Inferior Vena Cava Filters
8.8.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)
8.9. Embolectomy Balloon Catheters
8.9.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)
8.10. Percutaneous Thrombectomy Devices
8.10.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)
8.11. Catheter-Directed Thrombolysis (CDT) Devices
8.11.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)

9. Global Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2030 (US$ Bn)
9.1. Global Venous Thromboembolism (VTE) Treatment Market Overview, by Distribution Channel
9.1.1. Global Venous Thromboembolism (VTE) Treatment Market, By Distribution Channel, 2022 vs 2030 (in%)
9.2. Hospital Pharmacy
9.2.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)
9.3. Retail Pharmacy
9.3.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)
9.4. Online Pharmacy
9.4.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)

10. Global Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2030 (US$ Bn)
10.1. Global Venous Thromboembolism (VTE) Treatment Market Overview, by End-Users
10.1.1. Global Venous Thromboembolism (VTE) Treatment Market, By End-Users, 2022 vs 2030 (in%)
10.2. Hospitals
10.2.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)
10.3. Homecare
10.3.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)
10.4. Speciality Centres
10.4.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)
10.5. Others
10.5.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2017-2030 (US$ Bn)

11. Global Venous Thromboembolism (VTE) Treatment Market, By Region
11.1. Global Venous Thromboembolism (VTE) Treatment Market Overview, by Region
11.1.1. Global Venous Thromboembolism (VTE) Treatment Market, By Region, 2022 vs 2030 (in%)
11.2. Type
11.2.1. Global Venous Thromboembolism (VTE) Treatment Market, By Type, 2017-2030 (US$ Bn)
11.3. Product
11.3.1. Global Venous Thromboembolism (VTE) Treatment Market, By Product, 2017-2030 (US$ Bn)
11.4. Distribution Channel
11.4.1. Global Venous Thromboembolism (VTE) Treatment Market, By Distribution Channel, 2017-2030 (US$ Bn)
11.5. End-Users
11.5.1. Global Venous Thromboembolism (VTE) Treatment Market, By End-Users, 2017-2030 (US$ Bn)

12. North America Venous Thromboembolism (VTE) Treatment Market Analysis
12.1. North America Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. North America Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. North America Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. North America Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2030(US$ Bn)
12.4.1. Overview
12.4.2. SRC Analysis
12.5. North America Venous Thromboembolism (VTE) Treatment Market, by Country, 2017-2030 (US$ Bn)
12.5.1. North America Venous Thromboembolism (VTE) Treatment Market, by Country, 2022 Vs 2030 (in%)
12.5.2. U.S.
12.5.2.1. U.S. Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.2.2. U.S. Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
12.5.2.3. U.S. Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
12.5.2.4. U.S. Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
12.5.2.5. U.S. Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)
12.5.3. Canada
12.5.3.1. Canada Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.3.2. Canada Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
12.5.3.3. Canada Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
12.5.3.4. Canada Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
12.5.3.5. Canada Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)
12.5.4. Mexico
12.5.4.1. Mexico Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.4.2. Mexico Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
12.5.4.3. Mexico Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
12.5.4.4. Mexico Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
12.5.4.5. Mexico Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)

13. Europe Venous Thromboembolism (VTE) Treatment Market Analysis
13.1. Europe Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Europe Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2030(US$ Bn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Europe Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2030(US$ Bn)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. Europe Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2030(US$ Bn)
13.4.1. Overview
13.4.2. SRC Analysis
13.5. Europe Venous Thromboembolism (VTE) Treatment Market, by Country, 2017-2030 (US$ Bn)
13.5.1. Europe Venous Thromboembolism (VTE) Treatment Market, by Country, 2022 Vs 2030 (in%)
13.5.2. Germany
13.5.2.1. Germany Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.2.2. Germany Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
13.5.2.3. Germany Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
13.5.2.4. Germany Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
13.5.2.5. Germany Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)
13.5.3. France
13.5.3.1. France Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.3.2. France Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
13.5.3.3. France Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
13.5.3.4. France Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
13.5.3.5. France Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)
13.5.4. UK
13.5.4.1. UK Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.4.2. UK Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
13.5.4.3. UK Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
13.5.4.4. UK Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
13.5.4.5. UK Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)
13.5.5. Italy
13.5.5.1. Italy Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.5.2. Italy Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
13.5.5.3. Italy Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
13.5.5.4. Italy Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
13.5.5.5. Italy Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)
13.5.6. Spain
13.5.6.1. Spain Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.6.2. Spain Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
13.5.6.3. Spain Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
13.5.6.4. Spain Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
13.5.6.5. Spain Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)
13.5.7. Rest of Europe
13.5.7.1. Rest of Europe Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.7.2. Rest of Europe Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
13.5.7.3. Rest of Europe Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
13.5.7.4. Rest of Europe Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
13.5.7.5. Rest of Europe Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)

14. Asia Pacific Venous Thromboembolism (VTE) Treatment Market Analysis
14.1. Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2030(US$ Bn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2030(US$ Bn)
14.4.1. Overview
14.4.2. SRC Analysis
14.5. Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by Country, 2017-2030 (US$ Bn)
14.5.1. Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by Country, 2022 Vs 2030 (in%)
14.5.2. China
14.5.2.1. China Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.2.2. China Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
14.5.2.3. China Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
14.5.2.4. China Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
14.5.2.5. China Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)
14.5.3. Japan
14.5.3.1. Japan Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.3.2. Japan Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
14.5.3.3. Japan Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
14.5.3.4. Japan Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
14.5.3.5. Japan Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)
14.5.4. India
14.5.4.1. India Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.4.2. India Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
14.5.4.3. India Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
14.5.4.4. India Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
14.5.4.5. India Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)
14.5.5. South Korea
14.5.5.1. South Korea Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.5.2. South Korea Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
14.5.5.3. South Korea Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
14.5.5.4. South Korea Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
14.5.5.5. South Korea Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)
14.5.6. South-East Asia
14.5.6.1. South-East Asia Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.6.2. South-East Asia Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
14.5.6.3. South-East Asia Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
14.5.6.4. South-East Asia Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
14.5.6.5. South-East Asia Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)
14.5.7. Rest of Asia Pacific
14.5.7.1. Rest of Asia Pacific Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.7.2. Rest of Asia Pacific Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
14.5.7.3. Rest of Asia Pacific Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
14.5.7.4. Rest of Asia Pacific Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
14.5.7.5. Rest of Asia Pacific Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)

15. Latin America Venous Thromboembolism (VTE) Treatment Market Analysis
15.1. Latin America Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2030(US$ Bn)
15.1.1. Overview
15.1.2. SRC Analysis
15.2. Latin America Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2030(US$ Bn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Latin America Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2030(US$ Bn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Latin America Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2030(US$ Bn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. Latin America Venous Thromboembolism (VTE) Treatment Market, by Country, 2017-2030 (US$ Bn)
15.5.1. Latin America Venous Thromboembolism (VTE) Treatment Market, by Country, 2022 Vs 2030 (in%)
15.5.2. Brazil
15.5.2.1. Brazil Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.5.2.2. Brazil Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
15.5.2.3. Brazil Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
15.5.2.4. Brazil Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
15.5.2.5. Brazil Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)
15.5.3. Argentina
15.5.3.1. Argentina Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.5.3.2. Argentina Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
15.5.3.3. Argentina Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
15.5.3.4. Argentina Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
15.5.3.5. Argentina Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)
15.5.4. Rest of Latin America
15.5.4.1. Rest of Latin America Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.5.4.2. Rest of Latin America Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
15.5.4.3. Rest of Latin America Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
15.5.4.4. Rest of Latin America Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
15.5.4.5. Rest of Latin America Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)

16. Middle East and Africa Venous Thromboembolism (VTE) Treatment Market Analysis
16.1. Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2030(US$ Bn)
16.1.1. Overview
16.1.2. SRC Analysis
16.2. Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2030(US$ Bn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2030(US$ Bn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2030(US$ Bn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by Country, 2017-2030 (US$ Bn)
16.5.1. Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by Country, 2022 Vs 2030 (in%)
16.5.2. GCC Countries
16.5.2.1. GCC Countries Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.5.2.2. GCC Countries Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
16.5.2.3. GCC Countries Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
16.5.2.4. GCC Countries Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
16.5.2.5. GCC Countries Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)
16.5.3. South Africa
16.5.3.1. South Africa Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.5.3.2. South Africa Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
16.5.3.3. South Africa Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
16.5.3.4. South Africa Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
16.5.3.5. South Africa Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)
16.5.4. Rest of Middle East and Africa
16.5.4.1. Rest of Middle East and Africa Venous Thromboembolism (VTE) Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.5.4.2. Rest of Middle East and Africa Venous Thromboembolism (VTE) Treatment, By Type, 2017-2030 (US$ Bn)
16.5.4.3. Rest of Middle East and Africa Venous Thromboembolism (VTE) Treatment, By Product, 2017-2030 (US$ Bn)
16.5.4.4. Rest of Middle East and Africa Venous Thromboembolism (VTE) Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
16.5.4.5. Rest of Middle East and Africa Venous Thromboembolism (VTE) Treatment, By End-Users, 2017-2030 (US$ Bn)

17. Company Profiles
17.1. Pfizer Inc (U.S.)
17.1.1. Company Overview
17.1.2. Products/Services Portfolio
17.1.3. Geographical Presence
17.1.4. Financial Summary
17.1.4.1. Market Revenue and Net Profit (2019-2022)
17.1.4.2. Business Segment Revenue Analysis
17.1.4.3. Geographical Revenue Analysis
17.2. F. Hoffmann-La Roche Ltd (Switzerland)
17.3. Mylan N.V. (U.S.)
17.4. Aspen Holdings (U.S.)
17.5. Fresenius Kabi AG (Germany)
17.6. Hebei Changshan Biochemical Pharmaceutical Co. Ltd (China)
17.7. Hikma Pharmaceuticals PLC (U.K.)
17.8. Novartis AG (Switzerland)
17.9. Janssen Global Services LLC (U.S.)

List of Figures
FIG. 1 Global Venous Thromboembolism (VTE) Treatment Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom Up Approach
FIG. 3 Global Venous Thromboembolism (VTE) Treatment Market Segmentation
FIG. 4 Global Venous Thromboembolism (VTE) Treatment Market, by Type, 2022 (US$ Bn)
FIG. 5 Global Venous Thromboembolism (VTE) Treatment Market, by Product, 2022 (US$ Bn)
FIG. 6 Global Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2022 (US$ Bn)
FIG. 7 Global Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2022 (US$ Bn)
FIG. 8 Global Venous Thromboembolism (VTE) Treatment Market, by Geography, 2022 (US$ Bn)
FIG. 9 Attractive Investment Proposition, by Type, 2022
FIG. 10 Attractive Investment Proposition, by Product, 2022
FIG. 11 Attractive Investment Proposition, by Distribution Channel, 2022
FIG. 12 Attractive Investment Proposition, by End-Users, 2022
FIG. 13 Attractive Investment Proposition, by Geography, 2022
FIG. 14 Global Market Share Analysis of Key Venous Thromboembolism (VTE) Treatment Market Manufacturers, 2022
FIG. 15 Global Market Positioning of Key Venous Thromboembolism (VTE) Treatment Market Manufacturers, 2022
FIG. 16 Global Venous Thromboembolism (VTE) Treatment Market Value Contribution, By Type, 2022 & 2030 (Value %)
FIG. 17 Global Venous Thromboembolism (VTE) Treatment Market, by Deep Vein Thrombosis, Value, 2017-2030 (US$ Bn)
FIG. 18 Global Venous Thromboembolism (VTE) Treatment Market, by Pulmonary Embolism, Value, 2017-2030 (US$ Bn)
FIG. 19 Global Venous Thromboembolism (VTE) Treatment Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 20 Global Venous Thromboembolism (VTE) Treatment Market Value Contribution, By Product, 2022 & 2030 (Value %)
FIG. 21 Global Venous Thromboembolism (VTE) Treatment Market, by Non-Segmented Pneumatic Compression Pumps, Value, 2017-2030 (US$ Bn)
FIG. 22 Global Venous Thromboembolism (VTE) Treatment Market, by Segmented Pneumatic Compression Pumps without Gradient, 2017-2030 (US$ Bn)
FIG. 23 Global Venous Thromboembolism (VTE) Treatment Market, by Segmented Pneumatic Compression Pumps with Calibrated Gradient, Value, 2017-2030 (US$ Bn)
FIG. 24 Global Venous Thromboembolism (VTE) Treatment Market, by Upper Pneumatic Compression Sleeves, 2017-2030 (US$ Bn)
FIG. 25 Global Venous Thromboembolism (VTE) Treatment Market, by Lower Pneumatic Compression Sleeves, Value, 2017-2030 (US$ Bn)
FIG. 26 Global Venous Thromboembolism (VTE) Treatment Market, by Permanent Inferior Vena Cava Filters, 2017-2030 (US$ Bn)
FIG. 27 Global Venous Thromboembolism (VTE) Treatment Market, by Retrievable Inferior Vena Cava Filters, 2017-2030 (US$ Bn)
FIG. 28 Global Venous Thromboembolism (VTE) Treatment Market, by Embolectomy Balloon Catheters, 2017-2030 (US$ Bn)
FIG. 29 Global Venous Thromboembolism (VTE) Treatment Market, by Percutaneous Thrombectomy Devices, 2017-2030 (US$ Bn)
FIG. 30 Global Venous Thromboembolism (VTE) Treatment Market, by Catheter-Directed Thrombolysis (CDT) Devices, 2017-2030 (US$ Bn)
FIG. 31 Global Venous Thromboembolism (VTE) Treatment Market Value Contribution, By Distribution Channel, 2022 & 2030 (Value %)
FIG. 32 Global Venous Thromboembolism (VTE) Treatment Market, by Hospital Pharmacy, Value, 2017-2030 (US$ Bn)
FIG. 33 Global Venous Thromboembolism (VTE) Treatment Market, by Retail Pharmacy, 2017-2030 (US$ Bn)
FIG. 34 Global Venous Thromboembolism (VTE) Treatment Market, by Online Pharmacy, Value, 2017-2030 (US$ Bn)
FIG. 35 Global Venous Thromboembolism (VTE) Treatment Market Value Contribution, By End-Users, 2022 & 2030 (Value %)
FIG. 36 Global Venous Thromboembolism (VTE) Treatment Market, by Hospitals, Value, 2017-2030 (US$ Bn)
FIG. 37 Global Venous Thromboembolism (VTE) Treatment Market, by Homecare, 2017-2030 (US$ Bn)
FIG. 38 Global Venous Thromboembolism (VTE) Treatment Market, by Speciality Centres, Value, 2017-2030 (US$ Bn)
FIG. 39 Global Venous Thromboembolism (VTE) Treatment Market, by Others, 2017-2030 (US$ Bn)
FIG. 40 North America Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 41 U.S. Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 42 Canada Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 43 Europe Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 44 Germany Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 45 France Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 46 U.K. Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 47 Italy Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 48 Spain Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 49 Rest of Europe Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 50 Asia Pacific Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 51 China Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 52 Japan Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 53 India Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 54 South Korea Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 55 South-East Asia Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 56 Rest of Asia Pacific Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 57 Latin America Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 58 Brazil Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 59 Mexico Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 60 Rest of Latin America Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 61 Middle East & Africa Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 62 GCC Countries Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 63 South Africa Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)
FIG. 64 Rest of Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Venous Thromboembolism (VTE) Treatment Market
TABLE 2 Global Venous Thromboembolism (VTE) Treatment Market: Market Drivers Impact Analysis
TABLE 3 Global Venous Thromboembolism (VTE) Treatment Market: Market Restraints Impact Analysis
TABLE 4 Global Venous Thromboembolism (VTE) Treatment Market, by Competitive Benchmarking, 2022
TABLE 5 Global Venous Thromboembolism (VTE) Treatment Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Venous Thromboembolism (VTE) Treatment Market, by Key Strategies Analysis, 2022
TABLE 7 Global Venous Thromboembolism (VTE) Treatment Market, by Deep Vein Thrombosis, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Venous Thromboembolism (VTE) Treatment Market, by Deep Vein Thrombosis, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Venous Thromboembolism (VTE) Treatment Market, by Pulmonary Embolism, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Venous Thromboembolism (VTE) Treatment Market, by Pulmonary Embolism, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Venous Thromboembolism (VTE) Treatment Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Venous Thromboembolism (VTE) Treatment Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Venous Thromboembolism (VTE) Treatment Market, by Non-Segmented Pneumatic Compression Pumps, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Venous Thromboembolism (VTE) Treatment Market, by Non-Segmented Pneumatic Compression Pumps, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Venous Thromboembolism (VTE) Treatment Market, by Segmented Pneumatic Compression Pumps without Gradient, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Venous Thromboembolism (VTE) Treatment Market, by Segmented Pneumatic Compression Pumps without Gradient, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Venous Thromboembolism (VTE) Treatment Market, by Segmented Pneumatic Compression Pumps with Calibrated Gradient, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Venous Thromboembolism (VTE) Treatment Market, by Segmented Pneumatic Compression Pumps with Calibrated Gradient, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Venous Thromboembolism (VTE) Treatment Market, by Upper Pneumatic Compression Sleeves, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Venous Thromboembolism (VTE) Treatment Market, by Upper Pneumatic Compression Sleeves, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Venous Thromboembolism (VTE) Treatment Market, by Lower Pneumatic Compression Sleeves, By Region, 2017-2022 (US$ Bn)
TABLE 22 Global Venous Thromboembolism (VTE) Treatment Market, by Lower Pneumatic Compression Sleeves, By Region, 2023-2030 (US$ Bn)
TABLE 23 Global Venous Thromboembolism (VTE) Treatment Market, by Permanent Inferior Vena Cava Filters, By Region, 2017-2022 (US$ Bn)
TABLE 24 Global Venous Thromboembolism (VTE) Treatment Market, by Permanent Inferior Vena Cava Filters, By Region, 2023-2030 (US$ Bn)
TABLE 25 Global Venous Thromboembolism (VTE) Treatment Market, by Retrievable Inferior Vena Cava Filters, By Region, 2017-2022 (US$ Bn)
TABLE 26 Global Venous Thromboembolism (VTE) Treatment Market, by Retrievable Inferior Vena Cava Filters, By Region, 2023-2030 (US$ Bn)
TABLE 27 Global Venous Thromboembolism (VTE) Treatment Market, by Embolectomy Balloon Catheters, By Region, 2017-2022 (US$ Bn)
TABLE 28 Global Venous Thromboembolism (VTE) Treatment Market, by Embolectomy Balloon Catheters, By Region, 2023-2030 (US$ Bn)
TABLE 29 Global Venous Thromboembolism (VTE) Treatment Market, by Percutaneous Thrombectomy Devices, By Region, 2017-2022 (US$ Bn)
TABLE 30 Global Venous Thromboembolism (VTE) Treatment Market, by Percutaneous Thrombectomy Devices, By Region, 2023-2030 (US$ Bn)
TABLE 31 Global Venous Thromboembolism (VTE) Treatment Market, by Catheter-Directed Thrombolysis (CDT) Devices, By Region, 2017-2022 (US$ Bn)
TABLE 32 Global Venous Thromboembolism (VTE) Treatment Market, by Catheter-Directed Thrombolysis (CDT) Devices, By Region, 2023-2030 (US$ Bn)
TABLE 33 Global Venous Thromboembolism (VTE) Treatment Market, by Hospital Pharmacy, By Region, 2017-2022 (US$ Bn)
TABLE 34 Global Venous Thromboembolism (VTE) Treatment Market, by Hospital Pharmacy, By Region, 2023-2030 (US$ Bn)
TABLE 35 Global Venous Thromboembolism (VTE) Treatment Market, by Retail Pharmacy, By Region, 2017-2022 (US$ Bn)
TABLE 36 Global Venous Thromboembolism (VTE) Treatment Market, by Retail Pharmacy, By Region, 2023-2030 (US$ Bn)
TABLE 37 Global Venous Thromboembolism (VTE) Treatment Market, by Online Pharmacy, By Region, 2017-2022 (US$ Bn)
TABLE 38 Global Venous Thromboembolism (VTE) Treatment Market, by Online Pharmacy, By Region, 2023-2030 (US$ Bn)
TABLE 39 Global Venous Thromboembolism (VTE) Treatment Market, by Hospitals, By Region, 2017-2022 (US$ Bn)
TABLE 40 Global Venous Thromboembolism (VTE) Treatment Market, by Hospitals, By Region, 2023-2030 (US$ Bn)
TABLE 41 Global Venous Thromboembolism (VTE) Treatment Market, by Homecare, By Region, 2017-2022 (US$ Bn)
TABLE 42 Global Venous Thromboembolism (VTE) Treatment Market, by Homecare, By Region, 2023-2030 (US$ Bn)
TABLE 43 Global Venous Thromboembolism (VTE) Treatment Market, by Speciality Centers, By Region, 2017-2022 (US$ Bn)
TABLE 44 Global Venous Thromboembolism (VTE) Treatment Market, by Speciality Centers, By Region, 2023-2030 (US$ Bn)
TABLE 45 Global Venous Thromboembolism (VTE) Treatment Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 46 Global Venous Thromboembolism (VTE) Treatment Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 47 Global Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 48 Global Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 49 Global Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 50 Global Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 51 Global Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 52 Global Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 53 Global Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 54 Global Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 55 Global Venous Thromboembolism (VTE) Treatment Market, by Region, 2017-2022 (US$ Bn)
TABLE 56 Global Venous Thromboembolism (VTE) Treatment Market, by Region, 2023-2030 (US$ Bn)
TABLE 57 North America Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 58 North America Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 59 North America Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 60 North America Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 61 North America Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 62 North America Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 63 North America Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 64 North America Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 65 North America Venous Thromboembolism (VTE) Treatment Market, by Country, 2017-2022 (US$ Bn)
TABLE 66 North America Venous Thromboembolism (VTE) Treatment Market, by Country, 2023-2030 (US$ Bn)
TABLE 67 United States Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 68 United States Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 69 United States Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 70 United States Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 71 United States Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 72 United States Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 73 United States Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 74 United States Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 75 Canada Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 76 Canada Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 77 Canada Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 78 Canada Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 79 Canada Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 80 Canada Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 81 Canada Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 82 Canada Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 83 Mexico Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 84 Mexico Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 85 Mexico Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 86 Mexico Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 87 Mexico Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 88 Mexico Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 89 Mexico Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 90 Mexico Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 91 Europe Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 92 Europe Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 93 Europe Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 94 Europe Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 95 Europe Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 96 Europe Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 97 Europe Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 98 Europe Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 99 Europe Venous Thromboembolism (VTE) Treatment Market, by Country, 2017-2022 (US$ Bn)
TABLE 100 Europe Venous Thromboembolism (VTE) Treatment Market, by Country, 2023-2030 (US$ Bn)
TABLE 101 Germany Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 102 Germany Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 103 Germany Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 104 Germany Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 105 Germany Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 106 Germany Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 107 Germany Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 108 Germany Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 109 France Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 110 France Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 111 France Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 112 France Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 113 France Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 114 France Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 115 France Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 116 France Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 117 United Kingdom Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 118 United Kingdom Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 119 United Kingdom Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 120 United Kingdom Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 121 United Kingdom Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 122 United Kingdom Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 123 United Kingdom Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 124 United Kingdom Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 125 Italy Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 126 Italy Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 127 Italy Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 128 Italy Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 129 Italy Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 130 Italy Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 131 Italy Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 132 Italy Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 133 Spain Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 134 Spain Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 135 Spain Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 136 Spain Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 137 Spain Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 138 Spain Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 139 Spain Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 140 Spain Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 141 Rest of Europe Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 142 Rest of Europe Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 143 Rest of Europe Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 144 Rest of Europe Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 145 Rest of Europe Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 146 Rest of Europe Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 147 Rest of Europe Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 148 Rest of Europe Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 149 Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 150 Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 151 Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 152 Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 153 Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 154 Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 155 Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 156 Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 157 China Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 158 China Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 159 China Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 160 China Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 161 China Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 162 China Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 163 China Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 164 China Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 165 Japan Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 166 Japan Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 167 Japan Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 168 Japan Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 169 Japan Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 170 Japan Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 171 Japan Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 172 Japan Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 173 India Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 174 India Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 175 India Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 176 India Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 177 India Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 178 India Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 179 India Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 180 India Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 181 South Korea Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 182 South Korea Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 183 South Korea Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 184 South Korea Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 185 South Korea Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 186 South Korea Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 187 South Korea Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 188 South Korea Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 189 South-East Asia Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 190 South-East Asia Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 191 South-East Asia Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 192 South-East Asia Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 193 South-East Asia Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 194 South-East Asia Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 195 South-East Asia Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 196 South-East Asia Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 197 Rest of Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 198 Rest of Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 199 Rest of Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 200 Rest of Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 201 Rest of Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 202 Rest of Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 203 Rest of Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 204 Rest of Asia Pacific Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 205 Latin America Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 206 Latin America Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 207 Latin America Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 208 Latin America Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 209 Latin America Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 210 Latin America Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 211 Latin America Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 212 Latin America Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 213 Brazil Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 214 Brazil Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 215 Brazil Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 216 Brazil Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 217 Brazil Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 218 Brazil Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 219 Brazil Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 220 Brazil Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 221 Argentina Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 222 Argentina Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 223 Argentina Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 224 Argentina Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 225 Argentina Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 226 Argentina Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 227 Argentina Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 228 Argentina Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 229 Rest of Latin America Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 230 Rest of Latin America Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 231 Rest of Latin America Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 232 Rest of Latin America Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 233 Rest of Latin America Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 234 Rest of Latin America Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 235 Rest of Latin America Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 236 Rest of Latin America Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 237 Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 238 Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 239 Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 240 Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 241 Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 242 Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 243 Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 244 Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 245 GCC Countries Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 246 GCC Countries Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 247 GCC Countries Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 248 GCC Countries Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 249 GCC Countries Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 250 GCC Countries Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 251 GCC Countries Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 252 GCC Countries Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 253 South Africa Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 254 South Africa Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 255 South Africa Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 256 South Africa Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 257 South Africa Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 258 South Africa Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 259 South Africa Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 260 South Africa Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)
TABLE 261 Rest of Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by Type, 2017-2022 (US$ Bn)
TABLE 262 Rest of Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by Type, 2023-2030 (US$ Bn)
TABLE 263 Rest of Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 264 Rest of Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 265 Rest of Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 266 Rest of Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 267 Rest of Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2017-2022 (US$ Bn)
TABLE 268 Rest of Middle East and Africa Venous Thromboembolism (VTE) Treatment Market, by End-Users, 2023-2030 (US$ Bn)

Frequently Asked Questions:

How does COVID-19 impact the global venous thromboembolism (VTE) treatment market?

The global venous thromboembolism (VTE) treatment market has been negatively affected by the COVID-19 pandemic, leading to disruptions in healthcare services, delayed diagnosis and treatment, and increased risk of VTE.

Which is the leading region of the market for venous thromboembolism (VTE) treatments?

North America accounted for the most heightened global venous thromboembolism (VTE) treatment market share.

What are the key drivers for the growth of the venous thromboembolism (VTE) treatment market?

The increasing prevalence of VTE, greater awareness of the ailment and its associated issues, advancements in diagnostic techniques, and the development of innovative treatment options are the key factors driving the growth of the global venous thromboembolism (VTE) treatment market.

Which is the major segment in the venous thromboembolism (VTE) treatment market by product?

The catheter-directed thrombolysis (CDT) devices segment had a major share in the global market in 2022.

Which is the major segment in the venous thromboembolism (VTE) treatment market by distribution channel?

The hospital pharmacy segment had a major share in the global market.

Medical Devices

Artificial Cornea and Corneal Implant Market

Medical Devices

South Africa Prefilled Syringes Market

Medical Devices

Limb Prosthetics Market

Medical Devices

Automated Sample Digestion Systems Market

Medical Devices

Lung Biopsy Systems Market

Published Date: Oct 2023

Category: Medical Devices

Report ID: 62172

Report Format: PDF

No of Pages: 245

Medical Devices

Shock Wave Therapy Market

Published Date: Oct 2023

Category: Medical Devices

Report ID: 62189

Report Format: PDF

No of Pages: 266

Medical Devices

Single Use Flexible Endoscope Market

Published Date: Oct 2023

Category: Medical Devices

Report ID: 62188

Report Format: PDF

No of Pages: 233

Medical Devices

ENT Devices Market

Published Date: Oct 2023
Category: Medical Devices
Report ID: 58763
Report Format: PDF
No of Pages: 224

Medical Devices

Diabetes Drugs Market

Published Date: Oct 2023
Category: Medical Devices
Report ID: 58812
Report Format: PDF
No of Pages: 222

Medical Devices

Endodontic Devices Market

Published Date: Oct 2023
Category: Medical Devices
Report ID: 59584
Report Format: PDF
No of Pages: 254

Medical Devices

Clinical Laboratory Tests Market

Published Date: Oct. 2023
Category: Medical Devices
Report ID: 62149
Report Format: PDF
No of Pages: 220

Medical Devices

Blood Bag Tube Sealers Market

Published Date: Oct 2023

Category: Medical Devices

Report ID: 62159

Report Format: PDF

No of Pages: 250

Purchase Options

Buy With Trust, Competitive Pricing - In-depth Analysis

$2999

Delivery Format: Excel.

$4999

Designed for the individual purchaser.

$6999

Users located at a single corporate site or regional office.

$9999

Allowed for unlimited sharing globally within one company.


Still Not Sure?

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN
WhatsApp Now